We are live on ! Find out more
ACM

American Capital Management Portfolio holdings

AUM $1.86B
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+8.71%
1 Year Est. Return
+20.23%
3 Year Est. Return
+63.07%
5 Year Est. Return
+75.1%
10 Year Est. Return
+632.65%
AUM
$2.34B
AUM Growth
+$180M
Cap. Flow
+$24.5M
Cap. Flow %
1.05%
Top 10 Hldgs %
41.93%
Holding
71
New
2
Increased
37
Reduced
22
Closed
1

Top Sells

Rank Stock Value
1
CYBR
CyberArk
CYBR
+$10.8M
2
HOLX
Hologic
HOLX
+$9.91M
3
HCSG icon
Healthcare Services Group
HCSG
+$5.81M
4
ICLR icon
Icon
ICLR
+$3.24M
5
GNTX icon
Gentex
GNTX
+$2.97M

Sector Composition

Rank Sector Weight
1 Technology 41.6%
2 Healthcare 30.84%
3 Industrials 15.73%
4 Financials 6.33%
5 Consumer Discretionary 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBM
26
DELISTED
Cambrex Corporation
CBM
$37.3M 1.6%
796,906
+32,668
+4% +$1.37M
BLKB icon
27
Blackbaud
BLKB
$2.08B
$34.1M 1.46%
408,237
+30,930
+8% +$2.45M
LOGM
28
DELISTED
LogMein, Inc.
LOGM
$33.9M 1.45%
459,623
+7,260
+2% +$561K
MORN icon
29
Morningstar
MORN
$7.53B
$28.8M 1.23%
198,815
-13,990
-7% -$1.93M
OSUR icon
30
OraSure Technologies
OSUR
$279M
$28.4M 1.21%
3,055,473
+178,881
+6% +$1.65M
CRL icon
31
Charles River Laboratories
CRL
$12.8B
$25M 1.07%
175,950
TECH icon
32
Bio-Techne
TECH
$11.3B
$22M 0.94%
421,992
+2,412
+0.6% +$122K
TVTY
33
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$21.7M 0.93%
1,320,177
+81,823
+7% +$1.58M
IPGP icon
34
IPG Photonics
IPGP
$3.84B
$21.1M 0.9%
136,749
+4,200
+3% +$635K
ABMD
35
DELISTED
Abiomed Inc
ABMD
$20.9M 0.9%
+80,313
New +$21.3M
DORM icon
36
Dorman Products
DORM
$4.18B
$19.3M 0.82%
221,170
+75
+0% +$6.52K
HAE icon
37
Haemonetics
HAE
$4B
$19.1M 0.82%
158,735
-2,500
-2% -$246K
PRLB icon
38
Protolabs
PRLB
$2.13B
$16.1M 0.69%
138,772
-1,545
-1% -$166K
MMSI icon
39
Merit Medical Systems
MMSI
$5.32B
$15.9M 0.68%
267,425
-2,200
-0.8% -$126K
HCSG icon
40
Healthcare Services Group
HCSG
$1.53B
$15.9M 0.68%
525,207
-175,716
-25% -$5.81M
ACIW icon
41
ACI Worldwide
ACIW
$5.42B
$13.7M 0.58%
398,000
NATI
42
DELISTED
National Instruments Corp
NATI
$11.4M 0.49%
271,405
-4,670
-2% -$199K
ALRM icon
43
Alarm.com
ALRM
$2.85B
$9.55M 0.41%
178,500
+11,340
+7% +$700K
STRA icon
44
Strategic Education
STRA
$1.92B
$9.04M 0.39%
50,767
-957
-2% -$157K
CVLT icon
45
Commault Systems
CVLT
$5.61B
$8.93M 0.38%
180,000
+10,000
+6% +$532K
HQY icon
46
HealthEquity
HQY
$8.75B
$8.76M 0.37%
133,930
+23,795
+22% +$1.66M
DLB icon
47
Dolby
DLB
$5.79B
$7.5M 0.32%
116,021
+2,495
+2% +$159K
GHM icon
48
Graham Corp
GHM
$1.31B
$6.91M 0.3%
342,113
+30,115
+10% +$618K
FORR icon
49
Forrester Research
FORR
$224M
$6.63M 0.28%
140,960
-4,000
-3% -$193K
RGEN icon
50
Repligen
RGEN
$9.25B
$6.23M 0.27%
72,510
-830
-1% -$56.6K

Similar funds

American Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, American Capital Management held 71 positions worth $2.34B, up 8.4% from $2.16B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Trading was light in Q2 2019: portfolio turnover was 4.2%. American Capital Management opened 2 new positions and exited 1, leaving the 71-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 42% of assets, down from 44% a quarter earlier, followed by Healthcare and Industrials.

  • American Capital Management's largest Q2 2019 buy was Abiomed Inc: 80,313 shares worth $20.9M.
  • American Capital Management added most to Verint Systems in Q2 2019, an estimated $4.39M increase.
  • American Capital Management's biggest Q2 2019 reduction was CyberArk, cutting an estimated $10.8M.
  • American Capital Management fully exited NuVasive, Inc. in Q2 2019, selling an estimated $1.01M.
  • American Capital Management's ten largest holdings make up 42% of its $2.34B portfolio in Q2 2019.
  • American Capital Management opened 2 new positions and closed 1 in Q2 2019.
  • American Capital Management's portfolio value rose 8.4% quarter-over-quarter to $2.34B.

Based on American Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.